Window to Japan
The recombinant seasonal influenza HA vaccine ASP7374 contains three different strains of antigens and has been produced by a cell-culture manufacturing method employing the Baculovirus Expression Vector System (BEVS). The vaccine was developed in collaboration with UMN Pharma. Astellas Pharma news release, May 30, 2014
Genome analysis reveals how algae adapted to the terrestrial environment, an important step in plant evolution. Koichi HORI et al., Nature Communications, doi:10.1038/ncomms4978
Kyoto University’s CiRA (Professor Yamanaka and another 24 scientists ) received grants of over 5.7 billion Yen (about 40 million €), and 264 researchers (1.7 % of total sample) received over 100 million Yen (800.000 €). About 300 Japanese researchers achieved more than 100 million Yen each in competitive funding in FY 2013, CiRA was […]
The vaccine is based on encapsulated Bifidobacteria, and the patent was obtained both in the USA and Europe. Morishita Jintan news release, May 29, 2104
The group of Takashi YAMAMOTO which is engaged in artifical nuclease and genome editing research including CRISPR technologies was nominated by the Ministry of Education as a national hub in this field. Nikkei Biotech news release, May 29, 2014
The company, a comprehensive starch manufacturer, will study the taste quality of various sugars and artificial sweeteners. Nikkei Biotech, May 28, 2014
The consortium comprises the Kazusa DNA Research Institute, Yokohama City University and several research stations of MAFF. From 2014 – 2018, they will study strawberdry, peack, apple, carnation, chrysanthemum and tea with respect to DNA markers relevant for breeding. The implementation budget in 2014 is 60 million Yen. NARO news release, May 27, 2014
Yo TANAKA and colleagues have developed a valve formed by heat-sealing the ultra- thin glass of 6 μm thickness in a circular chamber of 3 mm diameter and 50 μm depth. It works with aqueous solution as well as with methanol, ethanol and acetone at maximum flow rates of 0,8 microliter per minute. RIKEN news […]
NIAS has published a protocol for breeding studies in the open field based on recombinant silkworms transformed with green fluorescent protein (EGFP), and experiments will be started in a defined facility without containment in June. NIAS press release, May 27, 2014
Researchers at Osaka University